**Author details**

Sandip Mitra and Kunaal Kharbanda\*

\*Address all correspondence to: k.kharbanda@nhs.net

Department of Nephrology, Central Manchester Foundation Trust, Manchester Academy of Health Sciences Centre (MAHSC), Manchester, United Kingdom

### **References**


[16] Lindström V, Grubb A, Alquist Hegbrant M, Christensson A. Different elimination patterns of beta‐trace protein, beta2‐microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration. Scand J Clin Lab Invest. 2008;68(8):685–91.

[3] Rao A, Casula A, Castledine C. UK renal registry 17th annual report: chapter 2 UK renal replacement therapy prevalence in 2013: national and centre‐specific analyses. Neph‐

[4] Steenkamp R, Rao A, Roderick P. UK renal registry 17th annual report: chapter 5 survival and cause of death in UK adult patients on renal replacement therapy in 2013: national and centre‐specific analyses. Nephron. Karger Publishers; 2015;129(s1):99–

[5] Thomson GE, Waterhouse K, McDonald HP, Friedman EA. Hemodialysis for chronic renal failure. Clinical observations. Arch Intern Med. 1967 Aug;120(2):153–67.

[6] Shaldon S, Silva H, Rosen SM. Technique of refrigerated coil preservation haemodial‐ ysis with femoral venous catheterization. Br Med J. 1964 Aug 15;2(5406):411–3.

[7] Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J

[8] Keshaviah P. Urea kinetic and middle molecule approaches to assessing the adequacy

[9] Lowrie EG, Zhu X, Lew NL. Primary associates of mortality among dialysis patients: trends and reassessment of Kt/V and urea reduction ratio as outcome‐based measures

[10] Foley RN, Gilbertson DT, Murray T, Collins AJ. Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med. 2011 Sep 22;365(12):

[11] Eckardt K‐U, Gillespie IA, Kronenberg F, Richards S, Stenvinkel P, Anker SD, et al. High cardiovascular event rates occur within the first weeks of starting hemodialysis.

[12] Henderson LW, Besarab A, Michaels A, Bluemle LW. Blood purification by ultrafiltra‐ tion and fluid replacement (diafiltration). Hemodial Int. 2004 Jan 1;8(1):10–8.

[13] Dhondt A, Vanholder R, Van Biesen W, Lameire N. The removal of uremic toxins.

[14] Leypoldt JK, Cheung AK, Carroll CE, Stannard DC, Pereira BJ, Agodoa LY, et al. Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient

[15] Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, et al. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2‐

microglobulin. Biochem Biophys Res Commun. 1985 Jun 28;129(3):701–6.

of hemodialysis and CAPD. Kidney Int Suppl. 1993 Feb;40:S28–38.

of dialysis dose. Am J Kidney Dis.; 1998 Dec;32(6):S16–31.

ron. Karger Publishers; 2015;129 Suppl 1(s1):31–56.

Med. 1981 Nov 12;305(20):1176–81.

Kidney Int. 2015 Apr 29;88(5):1117–25.

Kidney Int Suppl. 2000 Aug;76:S47–59.

survival. Am J Kidney Dis. 1999 Feb;33(2):349–55.

129.

114 Advances in Hemodiafiltration

1099–107.


[41] Parfrey PS. Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management. Nephrol Dial Transplant. 2000;15 Suppl 5:58–68.

[28] Glorieux G, Neirynck N, Veys N, Vanholder R. Dialysis water and fluid purity: more

[29] Rahmati MA, Homel P, Hoenich NA, Levin R, Kaysen GA, Levin NW. The role of improved water quality on inflammatory markers in patients undergoing regular

[30] Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS, Ecclestone AM, et al. Nocturnal hemodialysis: three‐year experience. J Am Soc Nephrol. 1998 May;9(5):859–68.

[31] Gossage‐Worrall R, Clift M, lowin J. CEP10061–Buyers' guide: home haemodialysis

[32] Woods JD, Port FK, Stannard D, Blagg CR, Held PJ. Comparison of mortality with home hemodialysis and center hemodialysis: a national study. Kidney Int. 1996 Jan 1;49(5):

[33] Marshall MR, HAWLEY CM, Kerr PG, Polkinghorne KR, Marshall RJ, Agar JWM, et al. Home hemodialysis and mortality risk in Australian and New Zealand populations.

[34] Arkouche W, Traeger J, Delawari E, Sibaï‐Galland R, Abdullah E, Galland R, et al. Twenty‐five years of experience with out‐center hemodialysis. Kidney Int. 1999 Dec;

[35] FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, et al. In‐ center hemodialysis six times per week versus three times per week. N Engl J Med.

[36] Rocco MV, Lockridge RS, Beck GJ, Eggers PW, Gassman JJ, Greene T, et al. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network

[37] Bergman A, Fenton SSA, Richardson RMA, Chan CT. Reduction in cardiovascular related hospitalization with nocturnal home hemodialysis. Clin Nephrol. 2008 Jan;

[38] Weinhandl ED, Nieman KM, Gilbertson DT, Collins AJ. Hospitalization in daily home hemodialysis and matched thrice‐weekly in‐center hemodialysis patients. Am J Kidney

[39] Saran R, Bragg‐Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with

[40] Movilli E, Gaggia P, Zubani R, Camerini C, Vizzardi V, Parrinello G, et al. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemo‐ dialysis. A 5‐year prospective observational multicentre study. Nephrol Dial Trans‐

reduced mortality in the DOPPS. Kidney Int. 2006 Apr;69(7):1222–8.

than endotoxin. Nephrol Dial Transplant. 2012 Nov;27(11):4010–21.

dialysis. Int J Artif Organs. 2004 Aug;27(8):723–7.

Am J Kidney Dis. 2011 Nov;58(5):782–93.

Nocturnal Trial. Kidney Int. 2011 Nov;80(10):1080–91.

devices. 2010 Mar 24;1–57.

1464–70.

116 Advances in Hemodiafiltration

56(6):2269–75.

69(1):33–9.

2010 Dec 9;363(24):2287–300.

Dis. 2015 Jan;65(1):98–108.

plant. 2007 Dec;22(12):3547–52.


[66] Suri RS, Larive B, Garg AX, Hall YN, Pierratos A, Chertow GM, et al. Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) trials. Nephrol Dial Transplant. 2011 Jul;26(7):2316–22.

[54] Chiu Y‐W, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients.

[55] Gutzwiller J‐P, Schneditz D, Huber AR, Schindler C, Gutzwiller F, Zehnder CE. Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis

[56] Al‐Hejaili F, Kortas C, Leitch R, Heidenheim AP, Clement L, Nesrallah G, et al. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate

[57] Lindsay RM, Alhejaili F, Nesrallah G, Leitch R, Clement L, Heidenheim AP, et al. Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis. 2003

[58] Ebah LM, Akhtar M, Wilde I, Hookway G, Vincent M, Reeves C, et al. Phosphate enrichment of dialysate for use in standard and extended haemodialysis. Blood Purif.

[59] Klarenbach S, Heidenheim AP, Leitch R, Lindsay RM, Daily/Nocturnal Dialysis Study Group. Reduced requirement for erythropoietin with quotidian hemodialysis therapy.

[60] Poon CKY, Tang H‐L, Wong JHS, Law W‐P, Lam C‐M, Yim K‐F, et al. Effect of alternate night nocturnal home hemodialysis on anemia control in patients with end‐stage renal

[61] Yuen D, Richardson RMA, Fenton SSA, McGrath‐Chong ME, Chan CT. Quotidian nocturnal hemodialysis improves cytokine profile and enhances erythropoietin

[62] McPhatter LL, Lockridge RS, Albert J, Anderson H, Craft V, Jennings FM, et al. Nightly home hemodialysis: improvement in nutrition and quality of life. Adv Ren Replace

[63] Heidenheim AP, Muirhead N, Moist L, Lindsay RM. Patient quality of life on quotidian

[64] Manns BJ, Walsh MW, Culleton BF, Hemmelgarn B, Tonelli M, Schorr M, et al. Nocturnal hemodialysis does not improve overall measures of quality of life compared

[65] Jaber BL, Lee Y, Collins AJ, Hull AR, Kraus MA, McCarthy J, et al. Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday‐Dialysis

Outcome Measurements) Study. Am J Kidney Dis. 2010 Sep;56(3):531–9.

Clin J Am Soc Nephrol. 2009 Jun;4(6):1089–96.

Jul;42(1 Suppl):24–9.

118 Advances in Hemodiafiltration

2012;34(1):28–33.

ASAIO J. 2002 Jan;48(1):57–61.

Ther. 1999 Oct;6(4):358–65.

disease. Hemodial Int. 2015 Apr;19(2):235–41.

responsiveness. ASAIO J. 2005 May;51(3):236–41.

hemodialysis. Am J Kidney Dis. 2003 Jul;42:36–41.

to conventional hemodialysis. Kidney Int. 2009 Mar;75(5):542–9.

dose. Nephrol Dial Transplant. 2002 Jun;17(6):1037–44.

calcium concentration. J Am Soc Nephrol. 2003 Sep;14(9):2322–8.


[93] AGAR JW. Review: understanding sorbent dialysis systems. Nephrology. 2010 Mar 19;15(4):406–11.

[79] Grooteman MPC, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AHA, et al. Effect of online hemodiafiltration on all‐cause mortality and

[80] Ok E, Asci G, Toz H, Ok ES, Kircelli F, Yilmaz M, et al. Mortality and cardiovascular events in online haemodiafiltration (OL‐HDF) compared with high‐flux dialysis: results from the Turkish OL‐HDF Study. Nephrol Dial Transplant. 2013 Jan;28(1):192–

[81] Lebourg L, Amato S, Toledano D, Petitclerc T, Créput C. Online hemodiafiltration: is

[82] Agar JWM. Reusing and recycling dialysis reverse osmosis system reject water. Kidney

[83] Penne EL, van der Weerd NC, Bots ML, van den Dorpel MA, Grooteman MPC, Lévesque R, et al. Patient‐ and treatment‐related determinants of convective volume in post‐dilution haemodiafiltration in clinical practice. Nephrol Dial Transplant. 2009

[84] Maduell F. Optimizing the prescription of hemodiafiltration. Contrib Nephrol.

[85] Maduell F, Navarro V, Torregrosa E, Rius A, Dicenta F, Cruz MC, et al. Change from three times a week on‐line hemodiafiltration to short daily on‐line hemodiafiltration.

[86] Kjellstrand CM, Kjellstrand P. The ideal home hemodialysis machine. Hemodial Int.

[87] Kitching AR, Ritchie D, Wong JK, May A, Hatfield PJ. Chloramine‐induced hemolysis associated with neurological symptoms in a home hemodialysis patient. Clin Nephrol.

[88] Freeman RM, Lawton RL, Chamberlain MA. Hard‐water syndrome. N Engl J Med. 1967

[89] Carlson DJ, Shapiro FL. Methemoglobinemia from well water nitrates: a complication

[90] Gallery ED, Blomfield J, Dixon SR. Acute zinc toxicity in haemodialysis. Br Med J. 1972

[91] Arnow PM. An outbreak of fatal fluoride intoxication in a long‐term hemodialysis unit.

[92] Schindler R, Beck W, Deppisch R, Aussieker M, Wilde A, Göhl H, et al. Short bacterial DNA fragments: detection in dialysate and induction of cytokines. J Am Soc Nephrol.

of home dialysis. Ann Intern Med. 1970 Nov;73(5):757–9.

Ann Intern Med. 1994 Sep 1;121(5):339–44.

cardiovascular outcomes. J Am Soc Nephrol. 2012 Jun;23(6):1087–96.

it really more expensive?. Nephrol Ther. 2013 Jul;9(4):209–14.

202.

120 Advances in Hemodiafiltration

Int. 2015 Oct;88(4):653–7.

Nov;24(11):3493–9.

2007;158:225–31.

Kidney Int. 2003 Jan 1;64(1):305–13.

2008 Jul;12 Suppl 1(s1):S33–9.

2001 Mar;55(3):259–60.

May 18;276(20):1113–8.

Nov 11;4(5836):331–3.

2004 Dec;15(12):3207–14.

